Influence of Bodily Practices on the Quality of Life of Women With Endometriosis
NCT06660043
Endometriosis, Female Urogenital Diseases
Chevry-Cossigny, France
View Trial DetailsNCT Number: NCT00938496
This is a prospective, open label NIS, which is to assess the efficacy of Zoladex in adjuvant setting after operation in moderate to severe endometriosis patients.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Research Site, Hefei, Anhui, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 18 months
Time frame: 18 months
Time frame: 6 months
Time frame: 18 months
Looking for future studies?
Notify MeAstraZeneca
Industry
A Non-interventional Study of Postoperative Treatment With Goserelin Acetate (Zoladex) in Moderate to Severe Endometriosis Patient
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06660043
Endometriosis, Female Urogenital Diseases
Chevry-Cossigny, France
View Trial DetailsNCT06215937
Endometriosis, Female Urogenital Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT07800442
Disease, Endometriosis
Warsaw, Poland
View Trial DetailsNCT07202741
Endometriosis, Female Urogenital Diseases
Istanbul, Turkey (Türkiye)
View Trial Details